Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:SRGA Surgalign (SRGA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis Get Surgalign alerts: Email Address About Surgalign Stock (NASDAQ:SRGA) 30 days 90 days 365 days Advanced Chart Ad Porter & CompanyThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the financial world in two the moment the polls close. I predict they could see investment losses of 50% (or more) in the weeks following the presidential election. Click here now to grab your seat now. Get Surgalign alerts:Sign Up Key Stats Today's Range N/A50-Day Range$0.18▼$1.2252-Week Range N/AVolume8.72 million shsAverage Volume1.44 million shsMarket Capitalization$1.69 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewSurgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spinal hardware implants and biomaterial products worldwide. It offers products for thoracolumbar procedures, including Streamline TL spinal fixation system, a system for degenerative and complex spine procedures; and Streamline MIS spinal fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops augmented reality and artificial intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. On June 19, 2023, Surgalign Holdings, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.Read More… The most serious warning of my career (Ad)With the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the financial world in two the moment the polls close. I predict they could see investment losses of 50% (or more) in the weeks following the presidential election. Click here now to grab your seat now. Receive SRGA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Surgalign and its competitors with MarketBeat's FREE daily newsletter. Email Address SRGA Stock News HeadlinesSurgalign Holdings Inc.November 4, 2023 | thestreet.comSurgalign Holdings Inc (SRGAQ)August 15, 2023 | investing.comThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the financial world in two the moment the polls close. I predict they could see investment losses of 50% (or more) in the weeks following the presidential election. September 25, 2024 | Porter & Company (Ad)RT20.BE - SURGALIGN HLDGS NEW -,001July 10, 2023 | finance.yahoo.comWhy Is Surgalign Holdings (SRGA) Stock Up 10% Today?June 27, 2023 | investorplace.comShort Volatility Alert: Surgalign HoldingsJune 26, 2023 | benzinga.comWhy Is Surgalign Holdings (SRGA) Stock Down 23% Today?June 26, 2023 | investorplace.comSurgalign Holdings, Inc.: Surgalign Receives NASDAQ Delisting Notice Following its Chapter 11 FilingJune 23, 2023 | finanznachrichten.deSee More Headlines SRGA Stock Analysis - Frequently Asked Questions How were Surgalign's earnings last quarter? Surgalign Holdings, Inc. (NASDAQ:SRGA) released its earnings results on Tuesday, November, 9th. The company reported ($3.60) earnings per share for the quarter, missing analysts' consensus estimates of ($2.70) by $0.90. The firm had revenue of $20.55 million for the quarter, compared to analyst estimates of $22.55 million. Surgalign had a negative trailing twelve-month return on equity of 983.11% and a negative net margin of 64.63%. When did Surgalign's stock split? Shares of Surgalign reverse split on Tuesday, May 17th 2022. The 1-30 reverse split was announced on Tuesday, May 17th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 17th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. Company Calendar Last Earnings11/09/2021Today9/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:SRGA CUSIPN/A CIK1760173 Webwww.surgalign.com Phone(224) 303-4651Fax386-418-0342Employees217Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($8.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-54,600,000.00 Net Margins-64.63% Pretax Margin-66.00% Return on Equity-983.11% Return on Assets-74.49% Debt Debt-to-Equity RatioN/A Current Ratio2.67 Quick Ratio2.00 Sales & Book Value Annual Sales$81.98 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($3.81) per share Price / BookN/AMiscellaneous Outstanding Shares9,240,000Free Float8,964,000Market Cap$1.69 million OptionableOptionable Beta1.55 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for October 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report This page (NASDAQ:SRGA) was last updated on 9/25/2024 by MarketBeat.com Staff From Our PartnersCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredAI Detects Profit Surge On MondayThis has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.Monument Traders Alliance | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThis Crypto Coin Could 10x FASTER Than BitcoinVenture Capital corporations and blockchain funds are pouring money into Web3 gaming. And there's one littl...Crypto 101 Media | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgalign Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surgalign With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.